Beam Therapeutics Inc. (BMV:BEAM)
Mexico
· Delayed Price · Currency is MXN 461.00
0.00 (0.00%)
At close: Dec 3, 2025
Beam Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Revenue | 55.7 | 63.52 | 377.71 | 60.92 | 51.84 | 0.02 | Upgrade
|
| Revenue Growth (YoY) | -84.07% | -83.18% | 520.01% | 17.51% | 215916.67% | 33.33% | Upgrade
|
| Cost of Revenue | 411.79 | 367.56 | 437.38 | 311.59 | 232.13 | 103.18 | Upgrade
|
| Gross Profit | -356.09 | -304.04 | -59.67 | -250.67 | -180.29 | -103.16 | Upgrade
|
| Selling, General & Admin | 110.2 | 111.53 | 116.81 | 87.81 | 57.22 | 29.61 | Upgrade
|
| Operating Expenses | 110.2 | 111.53 | 116.81 | 87.81 | 57.22 | 29.61 | Upgrade
|
| Operating Income | -466.29 | -415.57 | -176.49 | -338.48 | -237.51 | -132.76 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | - | Upgrade
|
| Interest & Investment Income | 44.02 | 49.09 | 46.68 | 15.3 | - | 1.05 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -25.5 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.52 | 2.27 | 7.5 | 23.9 | -1 | -63.4 | Upgrade
|
| EBT Excluding Unusual Items | -421.74 | -364.2 | -122.31 | -324.78 | -238.52 | -195.11 | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.18 | -14.09 | -18.59 | 20.2 | 17.69 | 0.52 | Upgrade
|
| Other Unusual Items | 0.92 | 1.59 | 9.74 | 18.9 | 5.15 | - | Upgrade
|
| Pretax Income | -414.64 | -376.7 | -131.16 | -285.68 | -370.64 | -194.59 | Upgrade
|
| Income Tax Expense | - | 0.04 | 1.37 | 3.41 | - | - | Upgrade
|
| Earnings From Continuing Operations | -414.64 | -376.74 | -132.53 | -289.09 | -370.64 | -194.59 | Upgrade
|
| Net Income | -414.64 | -376.74 | -132.53 | -289.09 | -370.64 | -194.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 1.28 | Upgrade
|
| Net Income to Common | -414.64 | -376.74 | -132.53 | -289.09 | -370.64 | -195.87 | Upgrade
|
| Shares Outstanding (Basic) | 94 | 82 | 77 | 70 | 64 | 47 | Upgrade
|
| Shares Outstanding (Diluted) | 94 | 82 | 77 | 70 | 64 | 47 | Upgrade
|
| Shares Change (YoY) | 14.73% | 6.69% | 10.19% | 9.01% | 37.44% | 621.24% | Upgrade
|
| EPS (Basic) | -4.42 | -4.58 | -1.72 | -4.13 | -5.77 | -4.19 | Upgrade
|
| EPS (Diluted) | -4.42 | -4.58 | -1.72 | -4.13 | -5.77 | -4.19 | Upgrade
|
| Free Cash Flow | -352.36 | -356.19 | -182.93 | -26.42 | -113.08 | -112.1 | Upgrade
|
| Free Cash Flow Per Share | -3.75 | -4.33 | -2.37 | -0.38 | -1.76 | -2.40 | Upgrade
|
| Gross Margin | - | - | -15.80% | - | - | - | Upgrade
|
| Operating Margin | -837.12% | -654.25% | -46.73% | -555.61% | -458.13% | -553166.67% | Upgrade
|
| Profit Margin | -744.41% | -593.13% | -35.09% | -474.54% | -714.91% | -816120.83% | Upgrade
|
| Free Cash Flow Margin | -632.59% | -560.77% | -48.43% | -43.38% | -218.11% | -467075.00% | Upgrade
|
| EBITDA | -444.22 | -393.64 | -156.47 | -324.33 | -230.06 | -128.03 | Upgrade
|
| EBITDA Margin | - | - | -41.43% | - | - | - | Upgrade
|
| D&A For EBITDA | 22.07 | 21.93 | 20.01 | 14.15 | 7.45 | 4.74 | Upgrade
|
| EBIT | -466.29 | -415.57 | -176.49 | -338.48 | -237.51 | -132.76 | Upgrade
|
| EBIT Margin | - | - | -46.73% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.